AI Co-Scientist Bridges Husband-and-Wife Labs to Tackle ALS

Google DeepMind's Co-Scientist, a multi-agent AI system, is enabling a novel collaborative approach to ALS research between MIT mechanical engineer Ritu Raman and Boston Children's Hospital chemical biologist Ryan Flynn. Raman builds living nerve and muscle tissues to model movement disorders, while Flynn maps RNA on cell surfaces to study cellular communication. When Raman faced a vast, contradictory ALS literature, Co-Scientist compressed months of reading into actionable insights, generating testable hypotheses ranked by feasibility and risk-reward. Its top leads pointed to cell-surface molecular interactions—outside Raman's expertise. This gap catalyzed a partnership: the couple used Co-Scientist iteratively to synthesize their distinct toolkits into creative research pathways. They are now hunting for novel RNA-based mechanisms and potential RNA-based drugs to target ALS. Raman emphasizes that Co-Scientist structures her thinking, clarifying what to ask collaborators, while Flynn notes it helps shift good ideas into more creative directions. The AI cannot do science alone, but accelerates interdisciplinary teamwork.